Recent advances in incretin-based therapy for the treatment of cognitive impairment associated to the type 2 diabetes mellitus: preclinical and clinical studies - a narrative review

Federica Giofrè, Isabella Zaffina, Maria Chiara Pelle, Franco Arturi · 2025

Read Recent advances in incretin-based therapy for the treatment of cognitive impairment associated to the type 2 diabetes mellitus: preclinical and clinical studies - a narrative review by Federica Giofrè, Isabella Zaffina, Maria Chiara Pelle, Franco Arturi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12753325.txt.

Description

Federica Giofrè leads a team that reviews incretin therapy for mind decline in diabetes. Their review from twenty twenty-five deals with type two diabetes. Diabetes raises the risk of mind impairment and dementia.

High blood sugar, insulin resistance, and swelling are linked. Keeping sugar at normal levels protects mind performance. GLP-1 drugs cut glucose and may guard the brain. The hormone acts on brain receptors as a signal. Preclinical and clinical studies are both surveyed. Memory, attention, and speed losses frame the decline. Attention and processing speed are named domains.

Catalog record

CREATORFederica Giofrè, Isabella Zaffina, Maria Chiara Pelle, Franco Arturi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12753325

Browse the full library · About the Tower of Babel